Search research articles
Contact Us
Filters
Showing results (181-190 of 309) with videos related to
Page
of 31
Sort By:
AIDS Research and Human Retroviruses
|
April 21, 2006
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients
Anna Bonjoch, Roger Paredes, Pere Domingo, et al.
Communications Medicine
|
December 8, 2025
Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._
Lucia Bailón, Yovaninna Alarcón-Soto, José R Arribas, et al.
Viruses
|
December 23, 2023
The Role of Late Presenters in HIV-1 Transmission Clusters in Europe
Mafalda N S Miranda, Victor Pimentel, Perpétua Gomes, et al.
Microbiome
|
May 13, 2019
Evolution of the gut microbiome following acute HIV-1 infection
Muntsa Rocafort, Marc Noguera-Julian, Javier Rivera, et al.
The Journal of Infectious Diseases
|
December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
Jonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Nature Communications
|
March 4, 2026
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Francesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
Nature Communications
|
April 27, 2026
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Francesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2026
Baseline resistance mutations and virological response to dolutegravir in treatment-naïve patients: a multicentre NGS study
Alexy Inciarte, Leire Berrocal, José R Santos, et al.
AIDS Research and Human Retroviruses
|
September 14, 2017
A Summary of the Second Annual HIV Microbiome Workshop
Brett Williams, Mimi Ghosh, Charles A B Boucher, et al.
The Journal of Antimicrobial Chemotherapy
|
October 23, 2015
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
José Ramón Santos, José Luis Blanco, Mar Masiá, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 309) with videos related to
Sort By:
Page
of 31
AIDS Research and Human Retroviruses
|
April 21, 2006
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients
Anna Bonjoch, Roger Paredes, Pere Domingo, et al.
Communications Medicine
|
December 8, 2025
Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._
Lucia Bailón, Yovaninna Alarcón-Soto, José R Arribas, et al.
Viruses
|
December 23, 2023
The Role of Late Presenters in HIV-1 Transmission Clusters in Europe
Mafalda N S Miranda, Victor Pimentel, Perpétua Gomes, et al.
Microbiome
|
May 13, 2019
Evolution of the gut microbiome following acute HIV-1 infection
Muntsa Rocafort, Marc Noguera-Julian, Javier Rivera, et al.
The Journal of Infectious Diseases
|
December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
Jonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Nature Communications
|
March 4, 2026
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Francesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
Nature Communications
|
April 27, 2026
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Francesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2026
Baseline resistance mutations and virological response to dolutegravir in treatment-naïve patients: a multicentre NGS study
Alexy Inciarte, Leire Berrocal, José R Santos, et al.
AIDS Research and Human Retroviruses
|
September 14, 2017
A Summary of the Second Annual HIV Microbiome Workshop
Brett Williams, Mimi Ghosh, Charles A B Boucher, et al.
The Journal of Antimicrobial Chemotherapy
|
October 23, 2015
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
José Ramón Santos, José Luis Blanco, Mar Masiá, et al.
Page
of 31